Bringing the Oncology Community Together

Dr. Lehman on Breast MRI and Mastectomy

Constance D. Lehman, MD, PhD
Published Online: Friday, September 13, 2013
Constance D. Lehman, MD, PhD, Vice Chair, Radiology Department, University of Washington School of Medicine, Medical Director, Imaging, Seattle Cancer Care Alliance, discusses how imaging can guide a women with breast cancer to make treatment decisions.

Lehman says that she has noticed a trend towards women opting for mastectomy rather than breast conservation surgery. Some physicians across the country were concerned that this trend was due to MRI in the sense that it could show more disease than expected on mammogram or ultrasound. In this situation, women may make a quick decision rather than wait to determine the best course of action.

The American College of Radiology Imaging Network (ACRIN) conducted a study in which women who underwent breast MRI at the time of diagnosis were analyzed. The study found that younger women, women with family history of breast cancer, and women with DCIS were all more likely to have mastectomy.

The study did not show that breast MRI was correlated with mastectomy, Lehman says. These findings are reassuring, Lehman says, as she does not want women to make decisions on mastectomy based on a suspicious MRI.
Related Articles
Experts Debate Utility of Genomic Profiling in Daily Practice
Although the potential for next-generation sequencing of breast cancer tumors to improve treatment strategies is widely recognized, questions swirl about the optimal use of such increasingly available technologies in clinical practice for today’s patients.
AR Findings Highlight Detailed Tumor-Profiling Study
A wide-ranging analysis of more than 5500 breast cancer tumors that combined genomic and protein expression testing has identified promising targets to explore for treating patients with poor prognoses, with particularly notable findings involving androgen receptor (AR) expression
Early Detection of Metastatic Prostate Cancer
In this segment, panelists discuss advanced imaging techniques that can be used to detect metastases earlier for patients with castration-resistant prostate cancer.
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.